{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:40:08Z","timestamp":1791398408535,"version":"4.3.3"},"reference-count":41,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To investigate whether altered megakaryocyte morphology contributes to reduced platelet production in idiopathic thrombocytopenic purpura (ITP), ultrastructural analysis of megakaryocytes was performed in 11 ITP patients. Ultrastructural abnormalities compatible with (para-)apoptosis were present in 78% \u00b1 14% of ITP megakaryocytes, which could be reversed by in vivo treatment with prednisone and intravenous immunoglobulin. Immunohistochemistry of bone marrow biopsies of ITP patients with extensive apoptosis showed an increased number of megakaryocytes with activated caspase-3 compared with normal (28% \u00b1 4% versus 0%). No difference, however, was observed in the number of bone marrow megakaryocyte colony-forming units (ITP, 118 \u00b1 93\/105 bone marrow cells; versus controls, 128 \u00b1 101\/105 bone marrow cells; P = .7). To demonstrate that circulating antibodies might affect megakaryocytes, suspension cultures of CD34+ cells were performed with ITP or normal plasma. Morphology compatible with (para-)apoptosis could be induced in cultured megakaryocytes with ITP plasma (2 of 10 samples positive for antiplatelet autoantibodies). Finally, the plasma glycocalicin index, a parameter of platelet and megakaryocyte destruction, was increased in ITP (57 \u00b1 70 versus 0.7 \u00b1 0.2; P = .009) and correlated with the proportion of megakaryocytes showing (para-) apoptotic ultrastructure (P = .02; r = 0.7). In conclusion, most ITP megakaryocytes show ultrastructural features of (para-) apoptosis, probably due to action of factors present in ITP plasma.<\/jats:p>","DOI":"10.1182\/blood-2003-01-0275","type":"journal-article","created":{"date-parts":[[2003,9,16]],"date-time":"2003-09-16T00:48:15Z","timestamp":1063673295000},"page":"500-506","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":250,"title":["Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura"],"prefix":"10.1182","volume":"103","author":[{"given":"Ewout J.","family":"Houwerzijl","sequence":"first","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nel R.","family":"Blom","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes J. L.","family":"van der Want","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariet T.","family":"Esselink","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Koornstra","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W.","family":"Smit","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Louwes","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Vellenga","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost Th. M.","family":"de Wolf","sequence":"additional","affiliation":[{"name":"From the Department of Hematology and Department of Medical Oncology, University Hospital Groningen, The Netherlands; Laboratory for Cell Biology and Electron Microscopy, University of Groningen, The Netherlands; and Department of Nuclear Medicine, Martini Hospital, Groningen, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021218362810500_REF1","doi-asserted-by":"crossref","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346: 995-1008.","DOI":"10.1056\/NEJMra010501"},{"key":"2020021218362810500_REF2","doi-asserted-by":"crossref","unstructured":"Harker LA. Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol. 1970;19: 95-104.","DOI":"10.1111\/j.1365-2141.1970.tb01605.x"},{"key":"2020021218362810500_REF3","doi-asserted-by":"crossref","unstructured":"Braneho\u0308g I, Kutti J, Ridell B, Swolin B, Weinfeld A. The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura (ITP). Blood. 1975;45: 551-562.","DOI":"10.1182\/blood.V45.4.551.551"},{"key":"2020021218362810500_REF4","doi-asserted-by":"crossref","unstructured":"Grossi A, Vannucchi AM, Casprini P, et al. Different patterns of platelet turnover in chronic idiopathic thrombocytopenic purpura. Scand J Haematol. 1983;31: 206-214.","DOI":"10.1111\/j.1600-0609.1983.tb00642.x"},{"key":"2020021218362810500_REF5","doi-asserted-by":"crossref","unstructured":"Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. J Clin Invest. 1987;80: 33-40.","DOI":"10.1172\/JCI113060"},{"key":"2020021218362810500_REF6","doi-asserted-by":"crossref","unstructured":"Louwes H, Zeinali Lathori OA, Vellenga E, de Wolf JThM. Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura. Am J Med. 1999;106: 430-434.","DOI":"10.1016\/S0002-9343(99)00054-6"},{"key":"2020021218362810500_REF7","doi-asserted-by":"crossref","unstructured":"McKenna JL, Pisciotta AV. Fluorescence of megakaryocytes in idiopathic thrombocytopenic purpura (ITP) stained with fluorescent antiglobulin serum. Blood. 1962;19: 664-675.","DOI":"10.1182\/blood.V19.6.664.664"},{"key":"2020021218362810500_REF8","doi-asserted-by":"crossref","unstructured":"McMillan R, Luiken GA, Levy R, Yelenosky R, Longmire RL. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA. 1978;239: 2460-2462.","DOI":"10.1001\/jama.239.23.2460"},{"key":"2020021218362810500_REF9","doi-asserted-by":"crossref","unstructured":"Hoffman R, Zaknoen S, Tang HH, et al. An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocyopenic purpura. N Engl J Med. 1985;312: 1170-1174.","DOI":"10.1056\/NEJM198505023121807"},{"key":"2020021218362810500_REF10","doi-asserted-by":"crossref","unstructured":"Takahashi R, Sekine N, Nakatake T. Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation. Blood. 1999;93: 1951-1958.","DOI":"10.1182\/blood.V93.6.1951.406a33_1951_1958"},{"key":"2020021218362810500_REF11","doi-asserted-by":"crossref","unstructured":"Chang M, Nakagawa PA, Williams SA, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood. 2003; 102: 887-895.","DOI":"10.1182\/blood-2002-05-1475"},{"key":"2020021218362810500_REF12","doi-asserted-by":"crossref","unstructured":"Steinberg MH, Kelton JG, Coller BS. Plasma glycocalicin. N Engl J Med. 1987;317: 1037-1042.","DOI":"10.1056\/NEJM198710223171701"},{"key":"2020021218362810500_REF13","unstructured":"Houwerzijl EJ, Louwes H, Smit JW, Esselink MT, Vellenga E, de Wolf JTM. Glycocalicin-index is elevated in ITP patients with a decreased platelet production rate in the platelet kinetic studies [abstract]. Blood. 2001;98: 525a."},{"key":"2020021218362810500_REF14","doi-asserted-by":"crossref","unstructured":"Bentfeld-Barker ME, Bainton DF. Ultrastructure of rat megakaryocytes after prolonged thrombocytopenia. J Ultrastruct Res. 1977;61: 201-214.","DOI":"10.1016\/S0022-5320(77)80087-7"},{"key":"2020021218362810500_REF15","doi-asserted-by":"crossref","unstructured":"Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer. 1994;73: 2013-2026.","DOI":"10.1002\/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J"},{"key":"2020021218362810500_REF16","doi-asserted-by":"crossref","unstructured":"Asher E, Payne CM, Bernstein C. Evaluation of cell death in EBV-transformed lymphocytes using agarose gel electrophoresis, light microscopy and electron microscopy. II. Induction of non-classic apoptosis (\u201cpara-apoptosis\u201d) by tritiated thymidine. Leuk Lymphoma. 1995;19: 107-119.","DOI":"10.3109\/10428199509059664"},{"key":"2020021218362810500_REF17","unstructured":"Tome ME, Baker AF, Powis G, Payne CM, Briehl MM. Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res. 2001;61: 2766-2773."},{"key":"2020021218362810500_REF18","doi-asserted-by":"crossref","unstructured":"Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A. 2000;97: 14376-14381.","DOI":"10.1073\/pnas.97.26.14376"},{"key":"2020021218362810500_REF19","doi-asserted-by":"crossref","unstructured":"Grossmann J, Walther K, Artinger M, Ru\u0308mmele P, Woenckhaus M, Scho\u0308lmerich J. Induction of apoptosis before shedding of human intestinal epithelial cells. Am J Gastroenterol. 2002;97: 1421-1428.","DOI":"10.1111\/j.1572-0241.2002.05787.x"},{"key":"2020021218362810500_REF20","doi-asserted-by":"crossref","unstructured":"Drayer AL, Sibinga CT, Blom NR, De Wolf JT, Vellenga E. The in vitro effects of cytokines and migration of megakaryocyte progenitor. Br J Haematol. 2000;109: 776-784.","DOI":"10.1046\/j.1365-2141.2000.02079.x"},{"key":"2020021218362810500_REF21","doi-asserted-by":"crossref","unstructured":"Beer JH, Bu\u0308chi L, Steiner B. Glycocalicin: a new assay\u2014the normal plasma levels and its potential usefulness in selected diseases. Blood. 1994;83: 691-702.","DOI":"10.1182\/blood.V83.3.691.691"},{"key":"2020021218362810500_REF22","doi-asserted-by":"crossref","unstructured":"Dameshek W, Miller EB. The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood. 1946;1: 27-50.","DOI":"10.1182\/blood.V1.1.27.27"},{"key":"2020021218362810500_REF23","unstructured":"Falca\u0303o L, Caen J, Gautier A. Etude e\u0301volutive de l'ultrastructure des me\u0301gakaryocytes dans un cas de purpura thrombope\u0301nique avant, 12 jours et 5 mois apre\u0300s sple\u0301nectomie. Blut. 1969;19: 156-171."},{"key":"2020021218362810500_REF24","unstructured":"Ridell B, Braneho\u0308g I. The ultrastructure of the megakaryocytes in idiopathic thrombocytopenic purpura (ITP) in relation to thrombokinetics. Pathol Eur. 1976;11; 179-187."},{"key":"2020021218362810500_REF25","doi-asserted-by":"crossref","unstructured":"Lambertenghi-Deliliers G, Polli N, Pozzoli E, Nava M, Soligo D. Ultrastructural alterations of megakaryocytes in some hematologic disorders. Tumori. 1981;67: 151-157.","DOI":"10.1177\/030089168106700213"},{"key":"2020021218362810500_REF26","doi-asserted-by":"crossref","unstructured":"Stahl CP, Zucker-Franklin D, McDonald TP. Incomplete antigen cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood. 1986;67: 421-428.","DOI":"10.1182\/blood.V67.2.421.421"},{"key":"2020021218362810500_REF27","unstructured":"Sugiyama H, Yagita M, Takahashi T, et al. Megakaryocytopoiesis in idiopathic thrombocytopenic purpura. Nippon Ketsueki Gakkai Zasshi. 1987;50: 119-128."},{"key":"2020021218362810500_REF28","doi-asserted-by":"crossref","unstructured":"Wang W, Matsuo T, Yoshida S, et al. Colony-forming unit-megakaryocyte (CFU-meg) numbers and serum thrombopoietin concentrations in thrombocytopenic disorders: an inverse correlation in myelodysplastic syndromes. Leukemia. 2000;14: 1751-1756.","DOI":"10.1038\/sj.leu.2401898"},{"key":"2020021218362810500_REF29","doi-asserted-by":"crossref","unstructured":"Abgrall JF, El-Kassar N, Berthou C, et al. In vitro megakaryocyte colony formation in patients with idiopathic thrombocytopenic purpura: differences between acute and chronic ITP. Int J Cell Cloning. 1992;10: 28-32.","DOI":"10.1002\/stem.5530100106"},{"key":"2020021218362810500_REF30","doi-asserted-by":"crossref","unstructured":"Abgrall JF, Berthou C, Sensebe\u0301 L, Le Niger C, Escoffre M. Decreased in vitro megakaryocyte colony formation in chronic idiopathic thrombocytopenic purpura. Br J Haematol. 1993;85: 803-804.","DOI":"10.1111\/j.1365-2141.1993.tb03227.x"},{"key":"2020021218362810500_REF31","doi-asserted-by":"crossref","unstructured":"Pisciotta AV, Stefanini M, Dameshek W. Studies on platelets. X. Morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood. 1953;8: 703-723.","DOI":"10.1182\/blood.V8.8.703.703"},{"key":"2020021218362810500_REF32","doi-asserted-by":"crossref","unstructured":"Hansen RJ, Balthasar JP. Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia. Blood. 2002;100: 2087-2093.","DOI":"10.1182\/blood.V100.6.2087"},{"key":"2020021218362810500_REF33","doi-asserted-by":"crossref","unstructured":"McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37: 239-248.","DOI":"10.1016\/S0037-1963(00)90102-1"},{"key":"2020021218362810500_REF34","doi-asserted-by":"crossref","unstructured":"Semple JW, Lazarus AH, Freedman J. The cellular immunology associated with autoimmune thrombocytopenic purpura: an update. Transfus Sci. 1998;19: 245-251.","DOI":"10.1016\/S0955-3886(98)00038-1"},{"key":"2020021218362810500_REF35","doi-asserted-by":"crossref","unstructured":"Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood. 1987;69: 820-826.","DOI":"10.1182\/blood.V69.3.820.820"},{"key":"2020021218362810500_REF36","doi-asserted-by":"crossref","unstructured":"Stefanelli M, Barosi G, Cazzola M, Orlandi E. Quantitative assessment of erythropoiesis in haemolytic disease. Br J Haematol. 1980;45: 297-308.","DOI":"10.1111\/j.1365-2141.1980.tb07149.x"},{"key":"2020021218362810500_REF37","doi-asserted-by":"crossref","unstructured":"Diggs LW, Hewlett JB. A study of the bone marrow from thirty-six patients with idiopathic hemorrhagic (thrombopenic) purpura. Blood. 1948;3: 1090-1104.","DOI":"10.1182\/blood.V3.10.1090.1090"},{"key":"2020021218362810500_REF38","doi-asserted-by":"crossref","unstructured":"Van de Loosdrecht AA, Hendriks DW, Blom NR, Smit JW, De Wolf JT, Vellenga E. Excessive apoptosis of bone marrow erythroblasts in a patient with autoimmune haemolytic anaemia with reticulocytopenia. Br J Haematol. 2000;108: 313-315.","DOI":"10.1046\/j.1365-2141.2000.01867.x"},{"key":"2020021218362810500_REF39","doi-asserted-by":"crossref","unstructured":"Heyns Adu P, Badenhorst PN, Lotter MG, Pieters H, Wessels P, Kotze HF. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled platelets and homologous 51Cr-labeled platelets differ. Blood. 1986;67: 86-92.","DOI":"10.1182\/blood.V67.1.86.86"},{"key":"2020021218362810500_REF40","doi-asserted-by":"crossref","unstructured":"Siegel RS, Rae JL, Barth S, et al. Platelet survival and turnover: important factors in predicting response to splenectomy in immune thrombocytopenic purpura. Am J Hematol. 1989;30: 206-212.","DOI":"10.1002\/ajh.2830300404"},{"key":"2020021218362810500_REF41","doi-asserted-by":"crossref","unstructured":"Louwes H, Vellenga E, Houwerzijl EJ, de Wolf JT. Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission. Ann Hematol. 2001;80: 728-732.","DOI":"10.1007\/s002770100375"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/2\/500\/1694279\/zh800204000500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/103\/2\/500\/1694279\/zh800204000500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:37:15Z","timestamp":1581554235000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/103\/2\/500\/17832\/Ultrastructural-study-shows-morphologic-features"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1,15]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-01-0275","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1,15]]}}}